Access to European Union law
<a href="https://eur-lex.europa.eu/content/help/eurlex-content/experimental-features.html" target="_blank">More about the experimental features corner</a>
Choose the experimental features you want to try
EUR-Lex
Access to European Union law

This document is an excerpt from the EUR-Lex website

You are here
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Search tips
Need more search options? Use the Advanced search

Document 62019TB0472

    Case T-472/19 R R: Order of the President of the General Court of 19 August 2019 — BASF v Commission (Interim measures – Medicinal product – Marketing authorisation – Omega-3 acid ethyl esters – No urgency)

    IO C 383, 11.11.2019, p. 61–62 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

    Date of document:
    19/08/2019
    Date lodged:
    09/07/2019
    Author:
    Cúirt Ghinearálta
    Form:
    Faisnéis bhreithiúnach
    Authentic language:
    Béarla
    Type of procedure:
    Iarratas ar bhearta eatramhacha, Caingean le haghaidh neamhniú
    Link
    Select all documents mentioning this document
    Case affecting:
    Instruments cited in case law:
    Link

    11.11.2019   

    EN

    Official Journal of the European Union

    C 383/61

    Order of the President of the General Court of 19 August 2019 — BASF v Commission

    (Case T-472/19 R R)

    (Interim measures - Medicinal product - Marketing authorisation - Omega-3 acid ethyl esters - No urgency)

    (2019/C 383/70)

    Language of the case: English

    Parties

    Applicant: BASF AS (Oslo, Norway) (represented by: E. Wright, A. Rusanov and H. Boland, lawyers)

    Defendant: European Commission (represented by: L. Haasbeek and A. Sipos, Agents)

    Re:

    Application pursuant to Articles 278 TFEU and 279 TFEU for the grant of interim measures to suspend the operation of the Commission Implementing Decision of 6 June 2019 concerning, in the framework of Article 31 of Directive 2001/83/EC, the marketing authorisations of medicinal products for human use containing ‘Omega-3 acid ethyl esters’ for oral use in secondary prevention after myocardial infarction (C(2019) 4336 final).

    Operative part of the order

    1.

    The application for interim measures is dismissed.

    2.

    The costs are reserved.

    Top